View Full Version : Aspirin Déjà vu

06-20-12, 06:40 PM
Jon Barron
June 18, 2012

Every year it seems there's another medical study testifying to the miraculous benefits of aspirin. It protects against heart disease and stroke, colon cancer, pancreatic cancer, and now, according to the latest studies, it may also help prevent skin, prostate, and lung cancers. The more one hears the more one begins to suspect that aspirin is the ultimate cure-all, the mythical "nectar of the gods."

Then again, perhaps not. We've previously discussed how many of aspirin's benefits are related to its ability to work as an anti-inflammatory -- and there are better ways to get that effect. And other recent but less well publicized studies indicate more strongly than ever before (and as I have been saying for years) that aspirin doesn't perform quite as well as advertised and that it comes with "aspirin side effects" that negate at least some of its questionable benefits.

Aspirin by itself is not really worth as many discussions as we've had on the subject; but the fact that the medical community, not to mention the aspirin manufacturers, keep finding ever new ways to promote the virtues of low-dose, daily aspirin means that we have to keep returning to the subject. With that in mind, let's take a look at the most recent studies and see what they actually mean.

To read the rest of the article go to: